Distinguished in Drowsiness

Mauro Manconi

Via Ospedale 72, 
Cagliari, IT 
Distinguished in Drowsiness
Via Ospedale 72, 
Cagliari, IT 
OverviewLocationsClinical Research

Overview

Mauro Manconi practices in Cagliari, Italy. Mr. Manconi is rated as a Distinguished expert by MediFind in the treatment of Drowsiness. His top areas of expertise are Restless Legs Syndrome, Periodic Limb Movement Disorder, Drowsiness, and Transient Ischemic Attack (TIA).

His clinical research consists of co-authoring 178 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 20 articles in the study of Drowsiness.

Gender
Male

Locations

Via Ospedale 72, Cagliari, 09124, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Sleep Deficiency and Sleep Fragmentation and Their Impact on the Short- and Long-term Outcome of Ischemic Stroke and Transient Ischemic Attacks - a Two-center Prospective Observational Cohort Study
Sleep Deficiency and Sleep Fragmentation and Their Impact on the Short- and Long-term Outcome of Ischemic Stroke and Transient Ischemic Attacks - a Two-center Prospective Observational Cohort Study
Enrollment Status: Completed
Publish Date: June 23, 2022
Chronobiology, Sleep Related Risk Factors and Light Therapy in Perinatal Depression: the Life-ON Project
Chronobiology, Sleep Related Risk Factors and Light Therapy in Perinatal Depression: the Life-ON Project
Enrollment Status: Completed
Publish Date: March 04, 2021
Intervention Type: Device
Study Phase: Not Applicable
Autonomic Function and Cardiovascular Risk in Restless Legs Syndrome: AUTOREST, a Case-control Study and a Randomized, Double-blind, Placebo-controlled, Parallel-group, 4-week, Multicenter Study of 0.25mg Pramipexole vs. Placebo in Patients With RLS
Autonomic Function and Cardiovascular Risk in Restless Legs Syndrome: AUTOREST, a Case-control Study and a Randomized, Double-blind, Placebo-controlled, Parallel-group, 4-week, Multicenter Study of 0.25mg Pramipexole vs. Placebo in Patients With RLS
Enrollment Status: Completed
Publish Date: January 24, 2017
Intervention Type: Drug
Study Phase: Phase 4
View 2 Less Clinical Trials

178 Total Publications

Partial endorsement of "Treatment of restless legs syndrome and periodic limb movement disorder: an AmericanAcademy ofSleep Medicine clinical practice guideline" by the World Sleep Society.
Partial endorsement of "Treatment of restless legs syndrome and periodic limb movement disorder: an AmericanAcademy ofSleep Medicine clinical practice guideline" by the World Sleep Society.
Journal: Sleep medicine
Published: August 05, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Manconi's expertise for a condition
ConditionClose
View All 7 Distinguished Conditions
View All 19 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile